8,700 Studies Reviewed. 87.0% Found Biological Effects. The Evidence is Clear.
Shield Your Body
Whole Body / General

Effects of moderate static magnetic fields on voltage-gated potassium ion channels in sympathetic neuron-like PC12 cells

Bioeffects Seen

Kaneda E, Kawai T, Okamura Y, Miyagawa S · 2025

Share:

Moderate static magnetic field exposure reduces potassium channel function in sympathetic neuron-like cells, potentially decreasing neuronal excitability through altered gene expression.

Plain English Summary

Summary written for general audiences

This study examined how moderate static magnetic fields affect voltage-gated potassium (Kv) channels in PC12 cells, a model for sympathetic neurons. Researchers found that 18 hours of magnetic field exposure significantly reduced Kv channel current density through effects on TEA-sensitive channels, with gene expression changes suggesting activation of neuronal inhibition pathways.

Why This Matters

This is an in vitro mechanistic study using PC12 cells, a well-established model system for studying neuronal ion channel function. The findings are limited to cellular-level effects and would require further investigation to determine relevance to whole-organism physiology or health outcomes.

Exposure Information

Specific exposure levels were not quantified in this study.

Watch: Video About This Study

Cite This Study
Kaneda E, Kawai T, Okamura Y, Miyagawa S (2025). Effects of moderate static magnetic fields on voltage-gated potassium ion channels in sympathetic neuron-like PC12 cells.
Show BibTeX
@article{kaneda_e_kawai_t_okamura_y_miyagawa_s_ce4427,
  author = {Kaneda E and Kawai T and Okamura Y and Miyagawa S},
  title = {Effects of moderate static magnetic fields on voltage-gated potassium ion channels in sympathetic neuron-like PC12 cells},
  year = {2025},
  doi = {10.1016/j.eclinm.2025.103338},
  
}
DOI: 10.1016/j.eclinm.2025.103338PubMed: 40119575

Quick Questions About This Study

This appears to be a database classification error. The EMPA-KIDNEY trial studied empagliflozin medication for chronic kidney disease, with no electromagnetic field exposure involved. Such misclassifications can contaminate EMF research databases.
No, empagliflozin is a standard pharmaceutical drug that inhibits glucose transporters in kidneys. It has no electromagnetic field generation or interaction properties. This study belongs in diabetes/nephrology research, not EMF literature.
Misclassified studies can inflate study counts in systematic reviews, introduce irrelevant data, and dilute genuine EMF findings. Researchers must carefully verify that included studies actually involve electromagnetic field exposure before drawing conclusions.
True EMF research must involve exposure to electromagnetic fields with specified frequencies, intensities, and durations. Studies should measure biological effects from radiofrequency, microwave, or extremely low frequency electromagnetic radiation sources.
Yes, unless the pharmaceutical specifically involves electromagnetic properties or EMF exposure is part of the study design. Standard drug trials like EMPA-KIDNEY have no relevance to electromagnetic field health effects research.